FLORASUN PAPAYE CAP 300MG DIN 02051990
Health Canada record
| Active ingredient(s) | PAPAYA 300 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1994 |
| Current status date | 01-Aug-2000 |
| Source | Health Canada DPD |
Establishment licence of the holder
Laboratoire Riva Inc. — licence 100179, currently licensed, last inspection rating C (2026-01-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PAPAYA
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02228033 | DIGESTION - CAP 300MG | LABORATOIRE LALCO INC. | Capsule | PAPAYA 300 MG | Cancelled Post Market |
| 02193965 | FORMULA FOUR - WAF | HILLESTAD PHARMACEUTICALS USA | Wafer | PAPAYA 115 MG; ASPERGILLUS NIGER 35 MG; ASPERGILLUS ORYZAE 30 MG; PINEAPPLE 25 MG | Cancelled Post Market |